Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

CD20-Negative Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphomas and Mature B-Cell Leukemia in Children, Adolescent and Young Adults: A Retrospective Review

Luciana Vinti, Jolanda Pianese, Elisa Carraro, Paola Muggeo, Daniela Onofrillo, Irene d'Alba, Elisabetta Schiavello, Raffaella De Santis, Concetta Micalizzi, Veronica Barat, Katia Perruccio, Luca Lo Nigro, Barbara Buldini, Lara Mussolin, Valentina Bertaina, Rita de Vito, Marta Pillon, Franco Locatelli

Blood (2024) 144 (Supplement 1): 3086.

https://doi.org/10.1182/blood-2024-208728

Published: 2024

Journal Articles

Novel Promising Therapeutic Strategies for Advancing the Treatment of KMT2A -Rearranged AML

Ambra Da Ros, Alberto Peloso, Giorgia Longo, Maddalena Benetton, Valentina Indio, Stefano Cairo, Monica Sandri, Barbara Buldini, Silvia Bresolin, Antonio Rosato, Andrea Pession, Claudia Tregnago, Franco Locatelli, Martina Pigazzi

Blood (2024) 144 (Supplement 1): 2910.

https://doi.org/10.1182/blood-2024-200132

Published: 2024

Journal Articles

Frequency and Early Prognostic Significance of Gene-Class Fusions Identified By RNA-Seq in Children and Adolescent with T-Cell Acute Lymphoblastic Leukemia Enrolled on AIEOP-BFM ALL 2017 Study

Blood (2024) 144 (Supplement 1): 4217.

https://doi.org/10.1182/blood-2024-207345

Published: 2024

Journal Articles

Results in Pediatric T-ALL Patients Treated in Trial AIEOP-BFM ALL 2009: Exploring Prognostic Factors in the Context of Modern Risk Adapted Therapy

Blood (2024) 144 (Supplement 1): 730.

https://doi.org/10.1182/blood-2024-201936

Published: 2024

Journal Articles

CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment

Blood (2024) 143 (17): 1738–1751.

https://doi.org/10.1182/blood.2023021952

Published: 2024

Includes: Supplemental data

Journal Articles

TCRαβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis

Blood (2024) 143 (3): 279–289.

https://doi.org/10.1182/blood.2023021336

Published: 2024

Includes: Supplemental data

Journal Articles

The Transcription Factors NFATc1 and NFATc2 Control Glucocorticoid Resistance in Pediatric T-Cell Acute Lymphoblastic Leukemia

Giulia Veltri, Alberto Peloso, Alice Cani, Elena Mariotto, Giulia Borile, Loris Russo, Chiara Frasson, Matilde Cescon, Egidio Iorio, Sonia Minuzzo, Panagiotis Ntziachristos, Alessandra Biffi, Barbara Buldini, Martina Pigazzi, Stefano Indraccolo, Silvia Bresolin, Valentina Serafin

Blood (2023) 142 (Supplement 1): 420.

https://doi.org/10.1182/blood-2023-181548

Published: 2023

Journal Articles

STAG2/LMO2 Gamma-Delta (γδ) T-ALL: Identification and Characterization of an Extremely High Risk Group of T-ALL in the Very Young

Shunsuke Kimura, Petri Pölönen, Lindsey Montefiori, Kenneth Caldwell, Ilaria Iacobucci, Chelsey Chen, Anthony Brown, Katie Han, Yen-Chun Liu, Yunchao Chang, Zhongshan Cheng, Zhou Yinmei, Chun Shik Park, Sharnise Mitchell, Noemi Reyes, Allen Yeoh, Andishe Attarbaschi, Andrew Moore, Atsushi Manabe, Barbara Buldini, Kean Hui Chiew, Chi Kong Li, Ching-Hon Pui, Chunxu Qu, Daisuke Tomizawa, Elisabeth Paietta, Franco Locatelli, Gabriele Escherich, Gao Qingsong, Hannah Elisa Muhle, Hanne Vibeke Marquart, Hester A. de Groot-Kruseman, Jacob M. Rowe, Jan Stary, Jan Trka, John Kim Choi, Jules P.P. Meijerink, Junko Takita, Katarzyna Pawinska-Wasikowska, Kjeld Schmiegelow, Mariko Eguchi, Martin Schrappe, Martin Zimmermann, Masatoshi Takagi, Melissa Maybury, Michael Svaton, Michaela Reiterova, Michal Kicinski, Motohiro Kato, Orietta Spinelli, Pauline Mazilier, Paul G. Thomas, Riccardo Masetti, Rishi Sury Kotecha, Rob Pieters, Sarah Elitzur, Selina M Luger, Shuhong Shen, Sima Jeha, Steven M. Kornblau, Szymon Skoczen, Takako Miyamura, Tiffaney Vincent, Toshihiko Imamura, Valentino Conter, Yanjing Tang, Zhaohui Gu, Kathryn G. Roberts, David T. Teachey, Kristine R Crews, Cheng Cheng, Jun J. Yang, Hiroto Inaba, Charles G. Mullighan

Blood (2023) 142 (Supplement 1): 845.

https://doi.org/10.1182/blood-2023-178688

Published: 2023

Journal Articles

Prognostic Role of Molecular MRD Variations during Treatment of Pediatric AML: A Retrospective AIEOP AML2013/01 Study

Martina Pigazzi, Maddalena Benetton, Pietro Merli, Rosanna Cuccurullo, Katia Polato, Pamela Scarparo, Manuela Tumino, Simone Cesaro, Rosa Maria Mura, Concetta Micalizzi, Claudia Tregnago, Carmelo Rizzari, Marco Zecca, Barbara Buldini, Franco Locatelli

Blood (2023) 142 (Supplement 1): 422.

https://doi.org/10.1182/blood-2023-186918

Published: 2023

Journal Articles

Drug Response Profiling Informs Personalized Bridging to Cell Therapy for Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

Blood (2023) 142 (Supplement 1): 4350.

https://doi.org/10.1182/blood-2023-179306

Published: 2023

Journal Articles

Characterization of the Molecular Landscape of Pediatric Acute Myeloid Leukemia: A Retrospective AIEOP AML2013/01 Study

Maddalena Benetton, Pietro Merli, Nicola Santoro, Luca Lo Nigro, Claudia Tregnago, Ambra Da Ros, Katia Polato, Veronica Zampieri, Barbara Michielotto, Samuela Francescato, Anna Leszl, Riccardo Masetti, Barbara Buldini, Alessandra Biffi, Franca Fagioli, Carmelo Rizzari, Franco Locatelli, Martina Pigazzi

Blood (2023) 142 (Supplement 1): 1580.

https://doi.org/10.1182/blood-2023-186458

Published: 2023

Journal Articles

Pre-Transplant Levels of Multiparametric Flow-Cytometry Measurable Residual Disease (MFC-MRD) Predict Outcomes in Children with Acute Myeloid Leukemia Given Allogeneic Hematopoietic Stem Cell Transplantation

Barbara Buldini, Pietro Merli, Elena Varotto, Riccardo Masetti, Maria Gabelli, Marco Zecca, Franca Fagioli, Pamela Scarparo, Mattia Algeri, Alessandra Biffi, Martina Pigazzi, Daria Pagliara, Franco Locatelli

Blood (2023) 142 (Supplement 1): 1590.

https://doi.org/10.1182/blood-2023-189080

Published: 2023

Journal Articles

Final Results of the AIEOP (Associazione Italiana Ematologia/Oncologia Pediatrica) AML 2013 Prospective Randomized Trial in Childhood Acute Myeloid Leukemia (AML)

Franco Locatelli, Barbara Buldini, Martina Pigazzi, Carmelo Rizzari, Rosanna Cuccurullo, Franca Fagioli, Manuela Tumino, Luca Lo Nigro, Maria Giuseppina Cefalo, Luisa Strocchio, Marco Zecca, Marco Becilli, Andrea Pession, Nicola Santoro, Concetta Micalizzi, Riccardo Masetti, Pietro Merli

Blood (2023) 142 (Supplement 1): 728.

https://doi.org/10.1182/blood-2023-188682

Published: 2023

Journal Articles

Plasma S-Evs Mirnas in Pediatric B Lineage Leukemia: Transforming Factors of Bone Marrow Niche

Alice Cani, Carlotta Caterina Damanti, Federica Lovisa, Enrico Gaffo, Giulia Borile, Elisa Carraro, Pina Fusco, Elena Varotto, Stefania Bortoluzzi, Alessandra Biffi, Barbara Buldini, Carmelo Rizzari, Marta Pillon, Lara Mussolin, Silvia Bresolin

Blood (2023) 142 (Supplement 1): 4081.

https://doi.org/10.1182/blood-2023-188680

Published: 2023

Journal Articles

Somatic and Germline Cohesin Genes Alterations in Pediatric Acute Lymphoblastic Leukemia

Blood (2023) 142 (Supplement 1): 1600.

https://doi.org/10.1182/blood-2023-189244

Published: 2023

Journal Articles

Crebbp Mutations Are Associated with Slow Minimal Residual Response to Upfront Induction Chemotherapy in Pediatric High-Hyperdiploid B-Cell Precursor Acute Lymphoblastic Leukemia Treated in the AIEOP-BFM ALL 2009 Protocol

Giacomo Gotti, Daniela Silvestri, Grazia Fazio, Chiara Palmi, Valentino Conter, Maria Grazia Valsecchi, Carmelo Rizzari, Barbara Buldini, Franco Locatelli, Andrea Biondi, Giovanni Cazzaniga

Blood (2023) 142 (Supplement 1): 4344.

https://doi.org/10.1182/blood-2023-187833

Published: 2023

Journal Articles

Preclinical Development of a CAR-T Cell Approach Targeting the CD84 Antigen Associated to Pediatric Acute Myeloid Leukemia

Martina Pigazzi, Olivia Marini, Elena Porcù, Giovanni Faggin, Elena Varotto, Paolo Rizzardi, Barbara Buldini, Franco Locatelli, Alessandra Biffi

Blood (2022) 140 (Supplement 1): 10247–10248.

https://doi.org/10.1182/blood-2022-166790

Published: 2022

Journal Articles

Ph-like and IKZF1plus Features in Children with Down Syndrome and B Cell Precursor Acute Lymphoblastic Leukemia

Blood (2022) 140 (Supplement 1): 6367–6368.

https://doi.org/10.1182/blood-2022-169131

Published: 2022

Journal Articles

CD72 Is a Pan-Tumor Antigen Associated with Childhood Acute Leukemia

Barbara Buldini, Giovanni Faggin, Elena Porcù, Pamela Scarparo, Katia Polato, Claudia Tregnago, Elena Varotto, Paolo Rizzardi, Carmelo Rizzari, Franco Locatelli, Alessandra Biffi, Martina Pigazzi

Blood (2022) 140 (Supplement 1): 4974–4975.

https://doi.org/10.1182/blood-2022-169040

Published: 2022

Journal Articles

Impact of Additional Intensive L-Asparaginase Therapy during Consolidation Phase for High-Risk Acute Lymphoblastic Leukemia: Results of a Randomized Controlled Trial in the AIEOP-BFM ALL 2009 Protocol

Blood (2022) 140 (Supplement 1): 109–111.

https://doi.org/10.1182/blood-2022-166583

Published: 2022

NARROW

CD20-Negative Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphomas and Mature B-Cell Leukemia in Children, Adolescent and Young Adults: A Retrospective Review

Novel Promising Therapeutic Strategies for Advancing the Treatment of KMT2A -Rearranged AML

Frequency and Early Prognostic Significance of Gene-Class Fusions Identified By RNA-Seq in Children and Adolescent with T-Cell Acute Lymphoblastic Leukemia Enrolled on AIEOP-BFM ALL 2017 Study

Results in Pediatric T-ALL Patients Treated in Trial AIEOP-BFM ALL 2009: Exploring Prognostic Factors in the Context of Modern Risk Adapted Therapy

CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment

TCRαβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis

The Transcription Factors NFATc1 and NFATc2 Control Glucocorticoid Resistance in Pediatric T-Cell Acute Lymphoblastic Leukemia

STAG2/LMO2 Gamma-Delta (γδ) T-ALL: Identification and Characterization of an Extremely High Risk Group of T-ALL in the Very Young

Prognostic Role of Molecular MRD Variations during Treatment of Pediatric AML: A Retrospective AIEOP AML2013/01 Study

Drug Response Profiling Informs Personalized Bridging to Cell Therapy for Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

Characterization of the Molecular Landscape of Pediatric Acute Myeloid Leukemia: A Retrospective AIEOP AML2013/01 Study

Pre-Transplant Levels of Multiparametric Flow-Cytometry Measurable Residual Disease (MFC-MRD) Predict Outcomes in Children with Acute Myeloid Leukemia Given Allogeneic Hematopoietic Stem Cell Transplantation

Final Results of the AIEOP (Associazione Italiana Ematologia/Oncologia Pediatrica) AML 2013 Prospective Randomized Trial in Childhood Acute Myeloid Leukemia (AML)

Plasma S-Evs Mirnas in Pediatric B Lineage Leukemia: Transforming Factors of Bone Marrow Niche

Somatic and Germline Cohesin Genes Alterations in Pediatric Acute Lymphoblastic Leukemia

Crebbp Mutations Are Associated with Slow Minimal Residual Response to Upfront Induction Chemotherapy in Pediatric High-Hyperdiploid B-Cell Precursor Acute Lymphoblastic Leukemia Treated in the AIEOP-BFM ALL 2009 Protocol

Preclinical Development of a CAR-T Cell Approach Targeting the CD84 Antigen Associated to Pediatric Acute Myeloid Leukemia

Ph-like and IKZF1plus Features in Children with Down Syndrome and B Cell Precursor Acute Lymphoblastic Leukemia

CD72 Is a Pan-Tumor Antigen Associated with Childhood Acute Leukemia

Impact of Additional Intensive L-Asparaginase Therapy during Consolidation Phase for High-Risk Acute Lymphoblastic Leukemia: Results of a Randomized Controlled Trial in the AIEOP-BFM ALL 2009 Protocol

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only